¿ÀÇÇ¿ÀÀÌµå »ç¿ë Àå¾Ö(OUD) ½ÃÀå : ¾àÁ¦ À¯Çüº°, Åõ¿© °æ·Îº°, À¯Åë ä³Îº°, ±¹°¡º°, Áö¿ªº° - »ê¾÷ ºÐ¼®, ½ÃÀå ±Ô¸ð, ½ÃÀå Á¡À¯À², ¿¹Ãø(2023-2030³â)
Opioid Use Disorder (OUD) Market, by Drug Type, by Route of Administration, by Distribution channel, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
»óǰÄÚµå : 1400996
¸®¼­Ä¡»ç : AnalystView Market Insights
¹ßÇàÀÏ : 2023³â 12¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 277 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 3,250 £Ü 4,612,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç, ÅØ½ºÆ®ÀÇ Copy&Pasteµµ ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 4,650 £Ü 6,598,000
PDF (5 User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 5,650 £Ü 8,017,000
PDF & Excel (Enterprise User License) help
PDF & Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ³» ¸ðµç »ç¿ëÀÚ°¡ »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy&Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¸®Æ÷Æ® ÇÏÀ̶óÀÌÆ®

¿ÀÇÇ¿ÀÀÌµå »ç¿ë Àå¾Ö(OUD) ½ÃÀå ±Ô¸ð´Â 2022³â¿¡ 28¾ï 10¸¸ ´Þ·¯¸¦ ±â·ÏÇßÀ¸¸ç, 2023-2030³â CAGR 10.59%·Î È®´ëÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¿ÀÇÇ¿ÀÀÌµå »ç¿ë Àå¾Ö(OUD) ½ÃÀå - ½ÃÀå ¿ªÇÐ

¿ÀÇÇ¿ÀÀ̵å Áßµ¶ ȯÀÚ Áõ°¡·Î ½ÃÀå ¼ö¿ä Áõ°¡

ÇöÀç ¼¼°è Àα¸´Â ½ÉÇ÷°ü Áúȯ, ¾Ï ¹× ±âŸ Áúº´À» Æ÷ÇÔÇÑ ´Ù¾çÇÑ ½É°¢ÇÑ ¸¸¼ºÁúȯ¿¡ ½Ã´Þ¸®°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¹®Á¦¸¦ Ä¡·áÇϱâ À§ÇØ ÁøÅëÁ¦, ƯÈ÷ ¿ÀÇÇ¿ÀÀ̵尡 »ç¿ëµË´Ï´Ù. ¾à¹° »ç¿ëÀº Á¾Á¾ ȯÀÚÀÇ ¾à¹° Áßµ¶À» À¯¹ßÇÕ´Ï´Ù. CDC¿¡ µû¸£¸é 2021³â ¹Ì±¹¿¡¼­´Â 12¼¼ ÀÌ»ó 270¸¸ ¸íÀÌ OUD¸¦ ¾ÎÀ» °ÍÀ¸·Î ¿¹»óµÇ¸ç, ÀÌ Áß ¾à¹°À» °©ÀÚ±â Áß´ÜÇÏ¸é ±Ý´ÜÁõ»óÀÌ ³ªÅ¸³¯ ¼ö ÀÖ½À´Ï´Ù.

¿ÀÇÇ¿ÀÀÌµå »ç¿ë Àå¾Ö(OUD) ½ÃÀå - ÁÖ¿ä ÀλçÀÌÆ®

AnalystView Market InsightsÀÇ ¸®¼­Ä¡ ¾Ö³Î¸®½ºÆ®°¡ °øÀ¯ÇÑ ºÐ¼®¿¡ µû¸£¸é ¼¼°è ¿ÀÇÇ¿ÀÀÌµå »ç¿ë Àå¾Ö(OUD) ½ÃÀåÀº ¿¹Ãø ±â°£(2023-2030³â) µ¿¾È ¾à 10.59%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)·Î ¸Å³â ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¿ÀÇÇ¿ÀÀ̵å Áßµ¶ ȯÀÚ Áõ°¡·Î ÀÎÇØ ¿ÀÇÇ¿ÀÀÌµå »ç¿ë Àå¾Ö(OUD) »ê¾÷Àº Å« ¼ºÀå·üÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¾à¹° À¯Çüº°·Î´Â ¾Æ°í´Ï½ºÆ®°¡ 2022³â °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

Åõ¿© °æ·Î¸¦ ¼¼ºÐÈ­Çϸé 2022³â¿¡´Â Á¤¸ÆÅõ¿©°¡ ÁÖ¿ä À¯ÇüÀ¸·Î ³ªÅ¸³µ½À´Ï´Ù.

À¯Åë ä³Îº°·Î´Â º´¿ø ¾à±¹ÀÌ 2022³â ÁÖ¿ä À¯ÇüÀ¸·Î ºÎ»óÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

Áö¿ªº°·Î´Â ºÏ¹Ì°¡ 2022³â ¸ÅÃâ 1À§¸¦ Â÷ÁöÇß½À´Ï´Ù.

¿ÀÇÇ¿ÀÀÌµå »ç¿ë Àå¾Ö(OUD) ½ÃÀå - ¼¼ºÐÈ­ ºÐ¼® :

¼¼°è ¿ÀÇÇ¿ÀÀÌµå »ç¿ë Àå¾Ö(OUD) ½ÃÀåÀº ¾à¹° À¯Çü, Åõ¿© °æ·Î, À¯Åë ä³Î ¹× Áö¿ª¿¡ µû¶ó ¼¼ºÐÈ­µË´Ï´Ù.

¾à¹° À¯Çüº°·Î´Â ÀÛ¿ëÁ¦, ±æÇ×Á¦, Ç×ÁøÁ¦ÀÇ ¼¼ °¡Áö·Î ºÐ·ùµË´Ï´Ù. ¸¸¼º ÅëÁõÀÇ ¹ß»ý·ü Áõ°¡, ¿ÀÇÇ¿ÀÀÌµå ¿À³²¿ë Áõ°¡, ÅëÁõ¼º Áúȯ¿¡ Ãë¾àÇÑ ³ëÀÎ Àα¸ Áõ°¡·Î ÀÎÇØ ÀÛ¿ëÁ¦ ºÎ¹®ÀÌ ½ÃÀåÀ» ÁÖµµÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

½ÃÀåÀº À¯Åë ä³Î¿¡ µû¶ó º´¿ø ¾à±¹°ú ¼Ò¸Å ¾à±¹ µÎ °¡Áö·Î ³ª´¹´Ï´Ù. º´¿ø ¾à±¹ ºÎ¹®Àº ºÎÇÁ·¹³ë¸£Çɰú °°Àº ºñ°æ±¸¿ë OUD Ä¡·áÁ¦ÀÇ Àü´Þ¿¡ ÀÖÀ¸¸ç, ȯÀÚ Áý´ÜÀÌ ÀÌ Ã¤³Î¿¡ ÀÇÁ¸Çϰí ÀÖÀ¸¹Ç·Î ¼¼°è ½ÃÀåÀÇ ´ëºÎºÐÀ» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¿ÀÇÇ¿ÀÀÌµå »ç¿ë Àå¾Ö(OUD) ½ÃÀå - Áö¿ªÀû ÀλçÀÌÆ®

Áö¿ªÀûÀ¸·Î ÀÌ ½ÃÀåÀº ºÏ¹Ì, ¶óƾ¾Æ¸Þ¸®Ä«, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«¿¡ ºÐÆ÷µÇ¾î ÀÖ½À´Ï´Ù. ÀÌ Áö¿ªÀº »ç¾÷ ¿î¿µ ±¹°¡¿¡ µû¶ó ´õ ¼¼ºÐÈ­µË´Ï´Ù. ºÏ¹Ì´Â ½ÃÀåÀ» ÁÖµµÇÒ °¡´É¼ºÀÌ ³ô½À´Ï´Ù. ÀÌ´Â ¹Ì±¹¿¡¼­ ¿ÀÇÇ¿ÀÀ̵å Áßµ¶À¸·Î °íÅë¹Þ´Â »ç¶÷µéÀÌ ¸¹°í, ÀÌ Áö¿ª¿¡ Áß¿äÇÑ ÀÌÇØ°ü°èÀÚ°¡ Á¸ÀçÇϸç, Áö¹æ Á¤ºÎ°¡ Àü¿°º´ ´ëÀÀ¿¡ µ¿ÂüÇϰí Àֱ⠶§¹®ÀÔ´Ï´Ù. 2020³â ¹Ì±¹ ±¹¸³»ý¹°°øÇÐÁ¤º¸¼¾ÅÍ(NCBI)°¡ ¹ßÇ¥ÇÑ ±â»ç¿¡ µû¸£¸é ¹Ì±¹¿¡¼­´Â ¾à 210¸¸ ¸íÀÌ ¿ÀÇÇ¿ÀÀÌµå »ç¿ë Àå¾Ö¸¦ ¾Î°í ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¿ÀÇÇ¿ÀÀÌµå »ç¿ë Àå¾Ö(OUD) ½ÃÀå °³¿ä

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ¿ÀÇÇ¿ÀÀÌµå »ç¿ë Àå¾Ö(OUD)ÀÇ ÁÖ¿ä ½ÃÀå µ¿Çâ

Á¦4Àå ¿ÀÇÇ¿ÀÀÌµå »ç¿ë Àå¾Ö(OUD) ¾÷°èÀÇ Á¶»ç

Á¦5Àå ¿ÀÇÇ¿ÀÀÌµå »ç¿ë Àå¾Ö(OUD) ½ÃÀå : COVID-19ÀÇ ¿µÇ⠺м®

Á¦6Àå ¿ÀÇÇ¿ÀÀÌµå »ç¿ë Àå¾Ö(OUD) ½ÃÀå ±¸µµ

Á¦7Àå ¿ÀÇÇ¿ÀÀÌµå »ç¿ë Àå¾Ö(OUD) ½ÃÀå : ¾àÁ¦ À¯Çüº°

Á¦8Àå ¿ÀÇÇ¿ÀÀÌµå »ç¿ë Àå¾Ö(OUD) ½ÃÀå : Åõ¿© °æ·Îº°

Á¦9Àå ¿ÀÇÇ¿ÀÀÌµå »ç¿ë Àå¾Ö(OUD) ½ÃÀå : À¯Åë ä³Îº°

Á¦10Àå ¿ÀÇÇ¿ÀÀÌµå »ç¿ë Àå¾Ö(OUD) ½ÃÀå : Áö¿ªº°

Á¦11Àå ÁÖ¿ä º¥´õ ºÐ¼® : ¿ÀÇÇ¿ÀÀÌµå »ç¿ë Àå¾Ö(OUD) ¾÷°è

Á¦12Àå ¾Ö³Î¸®½ºÆ®ÀÇ Àü¹æÀ§ Àü¸Á

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

REPORT HIGHLIGHT

Opioid Use Disorder (OUD) Market size was valued at USD 2,800.1 Million in 2022, expanding at a CAGR of 10.59% from 2023 to 2030.

Opioid Use Disorder (OUD) is a chronic health disorder defined by the obsessive and dangerous use of opioids, which can include prescribed medications as well as illegal narcotics such as heroin. It is characterized by a variety of symptoms, including cravings, withdrawal, tolerance, and poor social and vocational performance. Medication-assisted therapy and psychological support are frequently used in effective treatment to help patients recover control of their lives and minimize opiate dependence.

Opioid Use Disorder (OUD) Market- Market Dynamics

Increasing Opioid Addiction Cases to propel market demand

The worldwide population is currently afflicted with a wide spectrum of severe and chronic diseases, including cardiovascular ailments, cancer, and other conditions. To treat these problems, painkillers, particularly opioids, are used. Drug usage frequently leads to drug addiction in patients. Patients may develop drug withdrawal symptoms as a result of their increasing reliance on these treatments and their sudden discontinuation. According to the CDC, a projected 2.7 million persons aged 12 and over in the United States will have OUD in 2021.

Opioid Use Disorder (OUD) Market- Key Insights

As per the analysis shared by our research analyst, the global Opioid Use Disorder (OUD) market is estimated to grow annually at a CAGR of around 10.59% over the forecast period (2023-2030)

The Opioid Use Disorder (OUD) industry is projected to grow at a significant rate due to the increasing opioid addiction cases

Based on drug type segmentation, agonist was predicted to show maximum market share in the year 2022

Based on route of administration segmentation, Intravenous was the leading type in 2022

Based on distribution channel segmentation, hospital pharmacy was the leading type in 2022

On the basis of region, North America was the leading revenue generator in 2022

Opioid Use Disorder (OUD) Market- Segmentation Analysis:

The Global Opioid Use Disorder (OUD) Market is segmented on the basis of Drug Type, Route of Administration, Distribution channel, and Region.

The market is divided into three categories based on Drug Type: agonist and antagonist. Due to the rise in the incidence of chronic pain, a significant amount of opioid misuse, and the expanding elderly population susceptible to painful diseases, the agonist segment is predicted to dominate the market.

The market is divided into two categories based on distribution channel: hospital pharmacy and retail pharmacy. The hospital pharmacies segment is expected to account for a larger part of the worldwide market due to the patient population's reliance on this channel for the delivery of parenteral OUD medications such as buprenorphine.

Opioid Use Disorder (OUD) Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is likely to lead the market. This is due to the large number of people in the United States suffering from opioid addiction, the presence of significant stakeholders in the region, and the rising participation of local governments in combating the pandemic. According to a 2020 article released by the National Center for Biotechnology Information (NCBI), around 2.1 million people in the United States suffer with Opioid Use Disorder.

Opioid Use Disorder (OUD) Market- Competitive Landscape:

Due to the continued development in demand for air conditioning in the coming years, the worldwide market for air-to-air heat pumps is made of both international and local producers, making it one of the most competitive sectors in the world. Companies sell their products through a variety of channels, including corporate websites, e-commerce websites, retailers, distributors, and end consumers. Products makers compete on a variety of aspects, including product costs, performance, product making, Distribution channel, reputation, and availability. Some of the primary techniques used by corporations to strengthen their reach and expand their market share include new product launches, distribution network development, R&D spending, and mergers and acquisitions. For instance, April 2023, the New York State Office of Addiction Services and Supports (OASAS) and the New York State Department of Health (DOH) announced the introduction of the Buprenorphine Assistance Pilot Program, which will help with the expense of buprenorphine for opioid use disorder (OUD) treatment.

Recent Developments:

In March 2023, the acquisition of Opiant Pharmaceuticals, Inc. by Indivior PLC was finalized. The purchase will improve Indivior's position in the field of addiction therapy.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL OPIOID USE DISORDER (OUD) MARKET KEY PLAYERS

GLOBAL OPIOID USE DISORDER (OUD) MARKET, BY DRUG TYPE

GLOBAL OPIOID USE DISORDER (OUD) MARKET, BY ROUTE OF ADMINISTRATION

GLOBAL OPIOID USE DISORDER (OUD) MARKET, BY DISTRIBUTION CHANNEL

GLOBAL OPIOID USE DISORDER (OUD) MARKET, BY REGION

Table of Contents

1. Opioid Use Disorder (OUD) Market Overview

2. Executive Summary

3. Opioid Use Disorder (OUD) Key Market Trends

4. Opioid Use Disorder (OUD) Industry Study

5. Opioid Use Disorder (OUD) Market: COVID-19 Impact Analysis

6. Opioid Use Disorder (OUD) Market Landscape

7. Opioid Use Disorder (OUD) Market - By Drug Type

8. Opioid Use Disorder (OUD) Market - By Route of Administration

9. Opioid Use Disorder (OUD) Market - By Distribution Channel

10. Opioid Use Disorder (OUD) Market- By Geography

11. Key Vendor Analysis- Opioid Use Disorder (OUD) Industry

12. 360 Degree Analyst View

13. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â